Ala54Thr polymorphism of fatty acid binding protein 2, role on insulin resistance and cardiovascular risk factors in presurgical morbid obesity patients

Obesity Surgery

Volumn 19, Issue 12, 2009, Pages 1691-1696

  De Luis, D A ^a   Sagrado, M Gonzalez ^a   Aller, R ^a   Izaola, O ^a   Conde, R ^a   Romero, Enrique ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Adipokines; Cardiovascular risk factors; FABP2; Polymorphism; Presurgical morbid obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; FATTY ACID BINDING PROTEIN 2; GENOMIC DNA; INSULIN; INTERLEUKIN 6; LEPTIN; LIPID; LIPOPROTEIN A; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMINO ACID SUBSTITUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BARIATRIC SURGERY; BLOOD PRESSURE; BODY MASS; CALORIMETRY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIETARY INTAKE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NUTRITIONAL ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SURGICAL PATIENT;

ADIPOKINES; ADULT; ALANINE; ALLELES; C-REACTIVE PROTEIN; CHOLESTEROL; FATTY ACID-BINDING PROTEINS; FEMALE; GENE FREQUENCY; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY, MORBID; POLYMORPHISM, GENETIC; RISK FACTORS; THREONINE; TRIGLYCERIDES;

EID: 73949153200     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-009-9859-x     Document Type: Article

References (38)

1. M Rosenbaum RL Leibel J Hirsh 1997 Medical progress: obesity New Engl J Med 337 396 407 10.1056/NEJM199708073370606 1:STN:280:DyaK2sznslOjtA%3D%3D 9241130 (Pubitemid 27330711)
2. N Scopinaro GF Adami GM Marinari 1998 Biliopancreatic diversión World J Surg 22 936 946 10.1007/s002689900497 1:STN:280:DyaK1czotlWntQ%3D%3D 9717419 (Pubitemid 28374611)
3. DA de Luis D Pacheco R Aller, et al. 2008 Influence of -55CT polymorphism of UCP3 gene on surgical results of biliopancreatic diversion Obes Surg 10.1007/s11695-008-9510-2
4. DA de Luis M González Sagrado O Izaola, et al. 2008 Influence of Ala54Thr polymorphism of fatty acid-binding protein-2 on clinical results of biliopancreatic diversion Nutrition 24 300 304 10.1016/j.nut.2007.12.009 18280114
5. de Luis DA, Pacheco D, Aller R, et al. Influence of G308 polymorphism of Tumor necrosis alpha gene on surgical results of biliopancreatic diversion. Obes Surg 2008 (in press)
6. M Matsuda I Shimomura M Sata 2002 Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis J Biol Chem 277 37487 37491 10.1074/jbc.M206083200 1:CAS:528:DC%2BD38XnsVejs7o%3D 12138120
7. M Kumada S Kihara S Sumitsuji 2003 Association of hypoadiponectinemia with coronary artery disease in men Arterioscler Thromb Vasc Biol 23 85 89 10.1161/01.ATV.0000048856.22331.50 1:CAS:528:DC%2BD3sXhvFc%3D 12524229 (Pubitemid 36091630)
8. I Shimomoura RE Hammer S Ikemoto 1999 Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy Nature 401 73 76 10.1038/43448 (Pubitemid 29418444)
9. CM Steppan ST Bailey S Bhat 2001 The hormone resistin links obesity to diabetes Nature 409 307 312 10.1038/35053000 1:CAS:528:DC%2BD3MXms12nsA%3D%3D 11201732 (Pubitemid 32151228)
10. Y Matsuzawa 2005 Adipocytokines: emerging therapeutic targets Curr Atheroscler Rep 7 58 62 10.1007/s11883-005-0076-3 1:CAS:528: DC%2BD28XislOmtA%3D%3D 15683604
11. T Okasaki E Himeno H Nanri, et al. 1999 Effects of mild aerobic exercise and a mild hypocaloric diet on plasma leptin in sedentary women Clin Exp Pharmacol 26 415 420 10.1046/j.1440-1681.1999.03044.x (Pubitemid 29306958)
12. C Xenachis E Samojlik MP Raghuwanshi, et al. 2001 Leptin, insulin and TNF-alpha in weight loss J Endocrinol Invest 24 865 870 1:CAS:528: DC%2BD38XitVSntrg%3D 11817710
13. P Besnard 1996 Cellular and molecular aspects of fat metabolism in the small intestine Proc Nutr Soc 5 19 37
14. LJ Baier JC Sacchettini WC Knowler 1995 An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance J Clin Invest 95 1281 1287 10.1172/JCI117778 1:CAS:528:DyaK2MXktlKhu70%3D 7883976
15. C Albala JL Santos AC Viallaroel, et al. 2004 Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women Obes Res 12 340 345 10.1038/oby.2004.42 1:CAS:528:DC%2BD2cXislarurs%3D 14981227
16. MJ Duart CO Arroyo JL Moreno 2002 Validation of a insulin model for the reactions in RIA Clin Chem Lab Med 40 1161 1167 10.1515/CCLM.2002.203 (Pubitemid 36024452)
17. DR Mathews JP Hosker AS Rudenski, et al. 1985 Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 414 10.1007/BF00280883 (Pubitemid 15018832)
18. A Pfutzner M Langefeld T Kunt, et al. 2003 Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance Clin Lab 49 571 576 14651328
19. U Meier M Gressner 2004 Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin Clin Chem 50 1511 1525 10.1373/clinchem.2004.032482 1:CAS:528:DC%2BD2cXnsVaktb8%3D 15265818 (Pubitemid 39121218)
20. P Suominen 2004 Evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations Clin Chem 50 219 221 10.1373/clinchem.2003. 025833 1:CAS:528:DC%2BD2cXovFWmsA%3D%3D 14709655 (Pubitemid 38125726)
21. V Lubrano F Cocci D Battaglia, et al. 2005 Usefulness of high-sensitivity IL6 measurement for clinical characterization of patients with coronary artery disease J Clin Lab Anal 19 110 114 10.1002/jcla.20061 1:CAS:528: DC%2BD2MXlslKisLc%3D 15900566 (Pubitemid 40746135)
22. SS Khan MS Smith D Reda, et al. 2004 Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufactures Cytometry B Clin Cytom 61 35 39 10.1002/cyto.b.20021 15351980 (Pubitemid 39223368)
23. C Pichard D Slosman B Hirschel, et al. 1993 Bioimpedance analysis: an improved method for nutritional follow up Clin Res 41 53
24. Mataix J, Mañas M. Tablas de composición de alimentos españoles. Granada: University of Granada Ed; 2003.
25. ID Feurer JL Mullen 1986 Bedside measurement of resting energy expenditure and respiratory quotient via indirect calorimetry Nutr Clin Pract 1 43 49
26. R Sipilainen M Uusitupa S Heikkinen, et al. 1997 Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects J Clin Endocrinol Metab 82 2629 2632 10.1210/jc.82.8.2629 1:CAS:528:DyaK2sXltFGms7s%3D 9253345 (Pubitemid 27337884)
27. M Prochazka S Lillioja JF Tait 1993 Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians Diabetes 42 514 519 10.2337/diabetes.42.4.514 1:CAS:528:DyaK3sXitVGltLs%3D 8454101
28. BD Mitchell CM Kammerer P O'Connell 1995 Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP-2) in Mexican Americans Diabetes 44 1046 1053 10.2337/diabetes.44.9.1046 1:CAS:528:DyaK2MXotVGhurk%3D 7657027
29. KC Chiu LM Chuang C Yoon 2001 The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated with insulin resistance in glucose tolerant Caucasians BMC Genet 2 7 13 10.1186/1471-2156-2-7 1:STN:280: DC%2BD38nnslGjug%3D%3D 11299043 (Pubitemid 38751019)
30. K Yamada X Yuan S Ishimayama 1997 Association between Ala 54Thr substitution of the fatty acid binding protein 2 gene with insulin resistance and intra abdominal fat thickness in Japanese men Diabetologia 40 706 710 10.1007/s001250050737 1:STN:280:DyaK2szmsFyhtg%3D%3D 9222651 (Pubitemid 27288117)
31. CH Kim SK Yun DW Byun 2001 Codon 4 polymorphism of the fatty acid binding protein 2 gene is associated with increased fat oxidation and hyperinsulinemia but not with intestinal fatty acid absorption in Korean Men Metabolism 50 473 476 10.1053/meta.2001.21022 1:CAS:528:DC%2BD3MXis1Klu7c%3D 11288045 (Pubitemid 32321959)
32. DA de Luis MG Sagrado R Aler, et al. 2007 Influence of Ala54Thr polymorphism of fatty acid binding protein 2 on obesity and cardiovascular risk factors Horm Metab Res 39 380 384
33. A Georgopoulos O Aras MY Tsai 2000 Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes J Clin Endocr Metab 85 3155 3160 10.1210/jc.85.9.3155 1:CAS:528:DC%2BD3cXmsVKqsrw%3D 10999802
34. A Georgopoulos O Aras M Noutsou, et al. 2002 Unlike type 2 diabetes, type 1 does not interact with the codon 54 polymorphism of the fatty acid binding protein 2 gene J Clin Endocr 87 3735 3739 10.1210/jc.87.8.3735 1:CAS:528:DC%2BD38XmtF2gtrs%3D 12161503 (Pubitemid 34879520)
35. M Carlsson M Orho Melander J Hedenbro, et al. 2000 The T54 allele of the intestinal fatty acid-binding protein 2 is associated with parenteral history of stroke J Clin Endocr Metab 85 2801 2804 10.1210/jc.85.8.2801 1:CAS:528:DC%2BD3cXnslahs7o%3D 10946885 (Pubitemid 32269155)
36. NL Duarte S Colagiuri T Palu, et al. 2003 Obesity, type II diabetes and the Ala54 Thr polymorphism of fatty acid binding protein 2 in the Tongan population Mol Genet Metab 79 183 189 10.1016/S1096-7192(03)00088-X 1:CAS:528:DC%2BD3sXlt1ejur0%3D 12855223 (Pubitemid 36809045)
37. DA de Luis R Aller O Izaola, et al. 2006 Modulation of the response to a lifestyle modification in obese patients by ala54thr polymorphism of the fatty acid-binding protein 2 gene Ann Nutr Metab 50 354 360 10.1159/000094299 16809903 (Pubitemid 44174825)
38. DA de Luis R Aller O Izaola, et al. 2008 Influence of ALA54THR polymorphism of FABP-2 on weight loss and insulin levels secondary to two hypocaloric diets: a randomized clinical trial Diab Res Clin Pract 82 113 118 10.1016/j.diabres.2008.07.005 10.1016/j.diabres.2008.07.005